Gateway Checker

FDA recommends EPCIS for DSCSA drug traceability
  • Home
  • Our Approach
  • Q & A
    • Securing The US Drug Supply
    • How To Enable Traceability?
    • Why Conformance Checking Matters?
    • How To Become Gateway Certified?
    • How To Earn A GS1 Trustmark?
  • About Us
    • About Us
    • GS1 Certified Testing Service
  • Integrity Matters
  • Contact
  • Home
  • Our Approach
  • Q & A
    ▼
    • Securing The US Drug Supply
    • How To Enable Traceability?
    • Why Conformance Checking Matters?
    • How To Become Gateway Certified?
    • How To Earn A GS1 Trustmark?
  • About Us
    ▼
    • About Us
    • GS1 Certified Testing Service
  • Integrity Matters
  • Contact

Contact Us

Linkedin

  • Gateway Checker

    • Automated conformance testing to enable interoperable connectivity
    • Crafted by supply chain traceability experts
    • Certified by GS1 as a Conformance Testing Service.

    Why Gateway Checker?

  • Enabling Traceability

    • Exchanging transaction information with trading partners
    • Conforming to common language for connect compatibility
    • Certifying schema, structure, content per GS1 DSCSA Standards

    Securing the US Drug Supply

  • Recent News

    • Blue Link Partners with Gateway Checker to Help Pharma Distributors Meet DSCSA Interoperability Deadline
    • FDA recommends EPCIS for DSCSA drug traceability
    • Getting Ready: Drug Traceability
    • Enhanced Drug Distribution Security at the Package Level under DSCSA
    • FDA In Brief: FDA provides new guidance to further enhance the security of prescription drugs in the U.S. supply chain

  • Moving Forward

    • Request a traceability readiness assessment
    • Subscribe to receive updates
    • Contact Gateway Checker analysts

© 2023 Gateway Checker, All Rights Reserved. | Privacy Policy | Terms of Use | Acceptable Use Policy | Site Map